$21.98
0.78% day before yesterday
Nasdaq, Dec 20, 09:46 pm CET
ISIN
US71742Q1067
Symbol
PAHC

Phibro Animal Health Corporation Class A Target price 2024 - Analyst rating & recommendation

Phibro Animal Health Corporation Class A Classifications & Recommendation:

Hold
40%
Sell
60%

Phibro Animal Health Corporation Class A Price Target

Target Price $19.40
Price $21.69
Deviation
Number of Estimates 5
5 Analysts have issued a price target Phibro Animal Health Corporation Class A 2025 . The average Phibro Animal Health Corporation Class A target price is $19.40. This is lower than the current stock price. The highest price target is , the lowest is .
A rating was issued by 5 analysts: 0 Analysts recommend Phibro Animal Health Corporation Class A to buy, 2 to hold and 3 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Phibro Animal Health Corporation Class A stock has an average upside potential 2025 of . Most analysts recommend the Phibro Animal Health Corporation Class A stock at Sale.

Sales and Margin forecast 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Jun '24 2025
Estimates
Revenue Billion $ 1.02 1.18
4.07% 16.10%
EBITDA Margin 9.69% 13.22%
16.88% 36.45%
Net Margin 0.24% 3.92%
92.88% 1,541.69%

4 Analysts have issued a sales forecast Phibro Animal Health Corporation Class A 2025 . The average Phibro Animal Health Corporation Class A sales estimate is

$1.2b
Unlock
. This is
12.87% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$1.4b 30.14%
Unlock
, the lowest is
$1.0b 3.83%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $1.0b 4.07%
2025
$1.2b 16.10%
Unlock
2026
$1.3b 13.86%
Unlock
2027
$1.4b 1.01%
Unlock

4 Analysts have issued an Phibro Animal Health Corporation Class A EBITDA forecast 2025. The average Phibro Animal Health Corporation Class A EBITDA estimate is

$156m
Unlock
. This is
39.32% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$214m 91.34%
Unlock
, the lowest is
$107m 4.81%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $98.6m 13.50%
2025
$156m 58.39%
Unlock
2026
$188m 20.11%
Unlock
2027
$177m 5.87%
Unlock

EBITDA Margin

2024 9.69% 16.88%
2025
13.22% 36.45%
Unlock
2026
13.94% 5.45%
Unlock
2027
12.99% 6.81%
Unlock

4 Phibro Animal Health Corporation Class A Analysts have issued a net profit forecast 2025. The average Phibro Animal Health Corporation Class A net profit estimate is

$46.4m
Unlock
. This is
166.26% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$59.1m 239.53%
Unlock
, the lowest is
$27.1m 55.84%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $2.4m 92.59%
2025
$46.4m 1,808.23%
Unlock
2026
$65.0m 40.18%
Unlock
2027
$78.8m 21.29%
Unlock
2028
$107m 35.11%
Unlock

Net Margin

2024 0.24% 92.88%
2025
3.92% 1,541.69%
Unlock
2026
4.83% 23.21%
Unlock
2027
5.80% 20.08%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Jun '24 2025
Estimates
Earnings Per Share $ 0.06 1.15
92.59% 1,816.67%
P/E 18.94
EV/Sales 1.10

4 Analysts have issued a Phibro Animal Health Corporation Class A forecast for earnings per share. The average Phibro Animal Health Corporation Class A <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$1.15
Unlock
. This is
167.44% higher
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$1.46 239.53%
Unlock
, the lowest is
$0.67 55.81%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $0.06 92.59%
2025
$1.15 1,816.67%
Unlock
2026
$1.61 40.00%
Unlock
2027
$1.95 21.12%
Unlock
2028
$2.63 34.87%
Unlock

P/E ratio

Current 50.52 129.12%
2025
18.94 62.51%
Unlock
2026
13.51 28.67%
Unlock
2027
11.14 17.54%
Unlock
2028
8.25 25.94%
Unlock

Based on analysts' sales estimates for 2025, the Phibro Animal Health Corporation Class A stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.24 36.26%
2025
1.10 11.23%
Unlock
2026
0.97 12.18%
Unlock
2027
0.96 0.99%
Unlock

P/S ratio

Current 0.84 79.26%
2025
0.74 11.40%
Unlock
2026
0.65 12.18%
Unlock
2027
0.65 1.00%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today